首页> 外文期刊>Journal of Advanced Pharmaceutical Technology Research >The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases
【24h】

The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases

机译:过氧化物酶体增殖物激活受体:核受体家族在各种疾病中的作用

获取原文
           

摘要

Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors of nuclear hormone receptor superfamily comprising of the following three subtypes: PPARα, PPARγ, and PPARβ/δ. Activation of PPAR-α reduces triglyceride level and is involved in regulation of energy homeostasis. Activation of PPAR-γ causes insulin sensitization and enhances glucose metabolism, whereas activation of PPAR-β/δ enhances fatty acids metabolism. Thus, PPAR family of nuclear receptors plays a major regulatory role in energy homeostasis and metabolic function. The present review critically analyzes the protective and detrimental effect of PPAR agonists in dyslipidemia, diabetes, adipocyte differentiation, inflammation, cancer, lung diseases, neurodegenerative disorders, fertility or reproduction, pain, and obesity.Keywords: Diabetes, dyslipidemia, peroxisome proliferator-activated receptors
机译:过氧化物酶体增殖物激活受体(PPAR)是核激素受体超家族的配体激活转录因子,包括以下三种亚型:PPARα,PPARγ和PPARβ/δ。 PPAR-α的活化降低了甘油三酸酯的水平,并参与了能量稳态的调节。 PPAR-γ的激活引起胰岛素增敏并增强葡萄糖代谢,而PPAR-β/δ的激活增强脂肪酸代谢。因此,PPAR核受体家族在能量稳态和代谢功能中起主要调节作用。本文综述了PPAR激动剂在血脂异常,糖尿病,脂肪细胞分化,炎症,癌症,肺部疾病,神经退行性疾病,生育力或生殖,疼痛和肥胖症中的保护性和有害作用。关键词:糖尿病,血脂异常,过氧化物酶体增殖物激活受体

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号